Survival from head and neck cancers (HNCs) of the lip, oral cavity, pharynx, and larynx has
increased by 10% over the past few decades. Little over half of patients who develop HNCs …

Head and neck squamous cell carcinoma (HNSCC) represents a group of tumors arising in
the oral cavity, oropharynx, and larynx. Although HNSCC is traditionally associated with …

The incidence of oropharyngeal cancer (OPC) related to infection with human
papillomavirus (HPV) is rising, making it now the most common HPV-related malignancy in …

In the recent years, the prevalence of HPV-positive oropharyngeal squamous cell carcinoma
(OPSCC) has increased significantly. Currently, nearly 80-90% of all oropharynx tumors are …

Background and aim: Human papillomavirus (HPV) is sexually transmitted, one of the three
most common sexually transmitted infections (STIs) in both males and females, and the most …

Human papillomaviruses (HPVs) are the causative agent of several anogenital cancers as
well as head and neck cancers, with HPV+ head and neck squamous cell carcinoma …

BACKGROUND Human papillomavirus 16 (HPV16) E6 antibodies may be an early marker
of the diagnosis and recurrence of human papillomavirus–driven oropharyngeal cancer …

Infection with human papillomavirus (HPV) is one of the main causes of malignant
neoplasms, especially cervical, anogenital, and oropharyngeal cancers. Although we have …

Performance of commercially available human papillomavirus (HPV) assays (approved for
cervical HPV detection) is unknown for detecting HPV-related oropharyngeal cancer (HPV …

Purpose This study assessed the safety and tolerability of therapeutic immunization against
the human papillomavirus (HPV) viral oncoproteins E6 and E7 in patients with cervical …